THE SKIN HOUSE Wrinkle System EyeCream

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: THE SKIN HOUSE Wrinkle System EyeCream
Generic name: ADENOSINE
Manufacturer: NOKSIBCHO cosmetic Co., Ltd.
Product type: HUMAN OTC DRUG
SPL set ID: a2220aa2-953a-7b63-e053-2a95a90a6382
SPL ID: a2220aa2-953b-7b63-e053-2a95a90a6382
Version: 1
Effective date: 2020-03-31
Source export date: 2026-11-06
Source partition: 2
Source file: https://download.open.fda.gov/drug/label/drug-label-0002-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/4dafeb36642dffb72e2138939a956de402f722ea8c14c08cd87068efd3669f01/drug-label-0002-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 06:53:33

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 9 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		THE SKIN HOUSE Wrinkle System EyeCream	openfda.brand_name
generic name		ADENOSINE	openfda.generic_name
manufacturer name		NOKSIBCHO cosmetic Co., Ltd.	openfda.manufacturer_name
ndc	package	73590-0035-1	openfda.package_ndc
ndc	product	73590-0035	openfda.product_ndc
ndc11	package	73590003501	derived:openfda.package_ndc
spl id		a2220aa2-953b-7b63-e053-2a95a90a6382	id
spl set id		a2220aa2-953a-7b63-e053-2a95a90a6382	set_id
unii		K72T3FS567	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

For external use only When using this product ■ if the following symptoms occurs after use, stop use and consult with a skin specialist red specks, swelling, itching ■ don’t use on the part where there is injury, eczema, or dermatitis Keep out of reach of children ■ if swallowed, get medical help or contact a person control center immediately

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.